Eizo Inc. announced the release of the RadiForce RX650, a 30-inch color LCD monitor ideal for multi-modality applications.

A multidisciplinary team of experts in heart failure, cardiac arrhythmia and neurosurgery at Mount Sinai Hospital in New York City are testing nerve stimulation in the neck as a therapy for heart failure patients to potentially help relieve their debilitating symptoms of fatigue, shortness of breath and heart arrhythmias while reducing their hospitalizations.
The 2014 Top 10 Health Technology Hazards list raises awareness of the potential dangers associated with the use of medical devices and helps healthcare providers minimize the risk of technology-related adverse events.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Video game technology is being applied to imaging by German researchers, who will be presenting their findings at RSNA 2013. Xbox in the operating room and the use of video game controllers in visualizing organs and tumors, an ultra-sensitive MRI technology for early detection of cancer and a one-stop stroke management technology are among advances coming from scientists affiliated with the German Federal Ministry for Education and Research (BMBF):
Neovasc Inc. reported the results from its COSIRA (coronary sinus reducer for treatment of refractory angina) trial assessing the efficacy and safety of the Neovasc Reducer, a percutaneous device for the treatment of refractory angina.
Esaote will showcase Prevention Suite, a unique package of ultrasound imaging modalities for both cardiac and vascular investigations at the EuroEcho-Imaging 2013 conference Dec. 11-14 in Istanbul, Turkey.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in patient outcomes over the use of medications alone in treating hypertension. The results from the highly-anticipated CORAL trial were presented at the American Heart Assn. (AHA) 2013 Scientific Sessions in Dallas.

AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and Drug Administration’s (FDA’s) approval to begin enrollment in a clinical study of AtriCure’s AtriClip Left Atrial Appendage Exclusion System.
Five global MRI manufacturers—in the United States, Europe and Asia—have selected ContextVision’s GOPView MRI2Plus to upgrade their MRI equipment. Today’s healthcare industry requires improved efficiencies without sacrificing patient safety. As radiologists around the world review an increasing number of MRI images every day, image quality is key.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

Fractional flow reserve (FFR) is considered the gold standard in determining the hemodynamic significance of coronary lesions, but its use remains low. Two new technologies may help increase its use.

A German court ordered Nov. 14 the discontinuation of a prior court ruling that prohibited Medtronic from commercially marketing or selling the CoreValve transcatheter aortic valve replacement (TAVR) system in Germany since Aug. 26, 2013.
GE Healthcare will introduce new software to help humanize magnetic resonance imaging (MRI) with the DV24.0 Continuum Pak Silent Scan noiseless MRI at the Radiological Society of North America 2013 Annual Meeting (RSNA 2013) in Chicago.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The first two commercial implants of the Boston Scientific Lotus Valve System have taken place in a German hospital.
The U.S. Food and Drug Administration (FDA) has classified the Medtronic’s recently initiated voluntary recall of certain interventional guidewires as a Class I recall.

In an expert consensus document e-published in Catheterization and Cardiovascular Interventions (CCI), the Society for Cardiovascular Angiography and Interventions (SCAI) offers recommendations for optimal use of three technologies that interventional cardiologists often use to assess the severity of blockages in heart arteries.